GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,967 Cr | ₹3,410 Cr | ₹3,193 Cr | ₹4,520 Cr | ₹3,012 Cr |
What is the latest Total Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,967 Cr |
| Mar2024 | ₹3,410 Cr |
| Mar2023 | ₹3,193 Cr |
| Mar2022 | ₹4,520 Cr |
| Mar2021 | ₹3,012 Cr |
How is Total Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,967 Cr | 16.33 | |
| Mar2024 | ₹3,410 Cr | 6.80 | |
| Mar2023 | ₹3,193 Cr | -29.36 | |
| Mar2022 | ₹4,520 Cr | 50.09 | |
| Mar2021 | ₹3,012 Cr | - | |
Compare Total Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹40,145.3 Cr | -3.6% | -8.8% | 8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -3.6% |
-8.8% |
8.6% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses